share_log

Senti Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

SEC announcement ·  Jan 10 00:00
Summary by Moomoo AI
On January 10, 2024, Senti Biosciences, Inc., a biotechnology company based in South San Francisco, California, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission. This filing is intended to register additional shares for the company's 2022 Equity Incentive Plan and 2022 Employee Stock Purchase Plan. Specifically, 2,287,751 additional shares of common stock are being registered for the Equity Incentive Plan, and 457,550 additional shares for the Employee Stock Purchase Plan. The company, which is classified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, has incorporated by reference the contents of its previous Form S-8 filings from August 18, 2022, and February 16, 2023. The CEO and President, Timothy Lu, M.D., Ph.D., along with other executives and directors, have signed the registration statement, confirming the company's compliance with the requirements for filing on Form S-8.
On January 10, 2024, Senti Biosciences, Inc., a biotechnology company based in South San Francisco, California, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission. This filing is intended to register additional shares for the company's 2022 Equity Incentive Plan and 2022 Employee Stock Purchase Plan. Specifically, 2,287,751 additional shares of common stock are being registered for the Equity Incentive Plan, and 457,550 additional shares for the Employee Stock Purchase Plan. The company, which is classified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, has incorporated by reference the contents of its previous Form S-8 filings from August 18, 2022, and February 16, 2023. The CEO and President, Timothy Lu, M.D., Ph.D., along with other executives and directors, have signed the registration statement, confirming the company's compliance with the requirements for filing on Form S-8.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Doc 3

Doc 4

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more